Can AI Become Your Doctor? FDA Regulation, Medical Devices & the Future of Healthcare

Can AI Become Your Doctor? FDA Regulation, Medical Devices & the Future of Healthcare

Could artificial intelligence become your doctor someday? In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Alex Friedman, a regulatory affairs expert with deep experience in medical devices, FDA submissions, quality systems, and AI-enabled Software as a Medical Device.

Alex helps unpack one of the most important questions in healthcare innovation: when does software become a regulated medical device, and what happens when AI begins influencing clinical decisions?

The conversation moves from classic medical device classifications to 510(k) submissions, De Novo pathways, wearable health technology, clinical decision support software, adaptive AI, liability risk, and the future of “doctor-in-a-box” tools for underserved communities.

This episode is especially relevant for medical device developers, digital health founders, regulatory affairs professionals, biotech leaders, clinicians, investors, and anyone trying to understand how AI will be safely integrated into healthcare. Alex explains why regulatory strategy is not just bureaucracy. It is a public health safeguard designed to protect patients, validate claims, and prevent companies from selling unproven technology into high-stakes clinical environments.

As he puts it in the episode, “You can’t sell snake oil.” In this episode How FDA classifies medical devices by risk Why many Class II devices follow the 510(k) pathway What “substantial equivalence” means When software becomes a medical device Why AI-enabled software raises new regulatory questions How wearable technology may change cardiovascular monitoring Why medical claims create liability risk What makes adaptive AI especially difficult to regulate How FDA may approach predetermined change control plans Why inclusive training data matters for AI in healthcare How AI tools could improve care access in underserved communities

Featured guest Dr. Alex Friedman is a bioengineer and regulatory affairs professional with more than a decade of experience in medical devices, quality systems, FDA submissions, and regulatory strategy. His work includes AI-enabled hospital software, clinical decision support, and Software as a Medical Device.

Connect with Alex Friedman: https://www.linkedin.com/in/alexfriedman/

Charity spotlight Alex selected Americares, a nonprofit organization that delivers emergency medical aid and health programs to people affected by poverty and disaster.

Learn more: https://www.americares.org/

Links and resources All BioTalk Unzipped episodes: https://www.youtube.com/@BioTalkUnzipped/videos

BioTalk Unzipped LinkedIn: https://www.linkedin.com/company/biotalk-unzipped

Gregory Austin: https://www.linkedin.com/in/gregoryaustin1/

Dr. Chad Briscoe: https://www.linkedin.com/in/chadbriscoe/

Mentioned in the episode Antshrike cardiac health app from Before Health Intelligence: https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/new-ai-powered-mobile-app-delivers-early-prediction-of-heart-attack-or-stroke-944424

Fierce MedTech 2025 forecast on AI, regulators, and government: https://www.fiercebiotech.com/medtech/2025-forecast-how-will-ai-regulators-and-government-intersect SISU

Sense concussion mouthguard: https://www.sisuguard.com/sisusense/

HITIQ smart mouthguard: https://www.hitiq.com/smart-mouthguard

Prevent Biometrics: https://preventbiometrics.com/

IDX-DR diagnostic software: https://www.healthvisors.com/en/idx-dr/

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(43)

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Juni 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mars 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Dec 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min

Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai

Unlocking Antibody Development with AI with Dr. Pin-Kuang Lai

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe interview Asst. Professor Pin-Kuang Lai from Stevens Institute of Technology about his keynote speech at AAPS NBC 2025 an...

12 Sep 202517min

The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics

The Science and Hope of Brain Cancer with Dr. Robert Thorne, Denali Therapeutics

In this powerful episode (#35) of BioTalk Unzipped, recorded live at the AAPS NBC conference in Boston, Gregory Austin engages in a deep conversation with a leading Neuroscientist, Dr. Robert Thorne, ...

3 Juli 202522min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-borsens-finest
uppgang-och-fall
svd-tech-brief
avanzapodden
rss-svart-marknad
bathina-en-podcast
fill-or-kill
lastbilspodden
borsmorgon
rss-dagen-med-di
24fragor
dynastin
tabberaset
rikatillsammans-om-privatekonomi-rikedom-i-livet
rss-inga-dumma-fragor-om-pengar
kapitalet-en-podd-om-ekonomi
rss-kort-lang-analyspodden-fran-di